{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:56:52Z","timestamp":1790686612035,"version":"4.1.0"},"reference-count":237,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100012114","name":"Defence Research and Development Canada","doi-asserted-by":"publisher","award":["PEOPLE_037"],"award-info":[{"award-number":["PEOPLE_037"]}],"id":[{"id":"10.13039\/100012114","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s40122-026-00880-5","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:47:32Z","timestamp":1786978052000},"page":"1249-1279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Management of Musculoskeletal Injuries with an Inflammatory Damage-Associated Molecular Pattern (DAMP) Etiology"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1759-2957","authenticated-orcid":false,"given":"Ryan J.","family":"Love","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Funk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody-Lynn","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"issue":"s2","key":"880_CR1","first-page":"3","volume":"8","author":"F Tessier","year":"2022","unstructured":"Tessier F, Dubiniecki C, Carew M. Injury surveillance in the Canadian Armed Forces: an environmental scan. J Mil Vet Fam Health. 2022;8(s2):3\u201317.","journal-title":"J Mil Vet Fam Health"},{"issue":"10","key":"880_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1139\/apnm-2023-0029","volume":"48","author":"DF da Silva","year":"2023","unstructured":"da Silva DF, et al. Sex disparities in self-reported musculoskeletal injuries in the Canadian Armed Forces. Appl Physiol Nutr Metab. 2023;48(10):757\u201370.","journal-title":"Appl Physiol Nutr Metab"},{"issue":"3\u20134","key":"880_CR3","doi-asserted-by":"publisher","first-page":"e480","DOI":"10.1093\/milmed\/usz328","volume":"185","author":"I Dijksma","year":"2020","unstructured":"Dijksma I, et al. Epidemiology and financial burden of musculoskeletal injuries as the leading health problem in the military. Mil Med. 2020;185(3\u20134):e480\u20136.","journal-title":"Mil Med"},{"issue":"10","key":"880_CR4","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.jsams.2021.03.016","volume":"24","author":"M Lovalekar","year":"2021","unstructured":"Lovalekar M, et al. Musculoskeletal injuries in military personnel-descriptive epidemiology, risk factor identification, and prevention. J Sci Med Sport. 2021;24(10):963\u20139.","journal-title":"J Sci Med Sport"},{"key":"880_CR5","unstructured":"Theriault F, Gabler K, Naicker K. Health and lifestyle information survey of Canadian forces personnel 2013\/2014\u2014regular force report, B. Strauss and J. Whitehead, Editors. 2016, Department of National Defense."},{"issue":"1","key":"880_CR6","first-page":"2","volume":"2","author":"LJ H\u00e9bert","year":"2016","unstructured":"H\u00e9bert LJ. Are MSK injuries a hidden threat to the Canadian Armed Forces? J Mil Vet Fam Health. 2016;2(1):2\u20134.","journal-title":"J Mil Vet Fam Health"},{"issue":"1 Suppl","key":"880_CR7","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1016\/j.amepre.2009.10.021","volume":"38","author":"KG Hauret","year":"2010","unstructured":"Hauret KG, et al. Musculoskeletal injuries description of an under-recognized injury problem among military personnel. Am J Prev Med. 2010;38(1 Suppl):S61-70.","journal-title":"Am J Prev Med"},{"issue":"9\u201310","key":"880_CR8","doi-asserted-by":"publisher","first-page":"e1461","DOI":"10.1093\/milmed\/usaa027","volume":"185","author":"JM Molloy","year":"2020","unstructured":"Molloy JM, et al. Musculoskeletal injuries and United States Army readiness part I: overview of injuries and their strategic impact. Mil Med. 2020;185(9\u201310):e1461\u201371.","journal-title":"Mil Med"},{"issue":"4","key":"880_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.csm.2014.06.004","volume":"33","author":"KL Cameron","year":"2014","unstructured":"Cameron KL, Owens BD. The burden and management of sports-related musculoskeletal injuries and conditions within the US military. Clin Sports Med. 2014;33(4):573\u201389.","journal-title":"Clin Sports Med"},{"issue":"3\u20134","key":"880_CR10","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1093\/milmed\/usaa304","volume":"187","author":"TC Mauntel","year":"2022","unstructured":"Mauntel TC, et al. The Military Orthopedics Tracking Injuries and Outcomes Network: a solution for improving musculoskeletal care in the military health system. Mil Med. 2022;187(3\u20134):e282\u20139.","journal-title":"Mil Med"},{"issue":"2","key":"880_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2165\/00007256-199214020-00002","volume":"14","author":"W van Mechelen","year":"1992","unstructured":"van Mechelen W, Hlobil H, Kemper HC. Incidence, severity, aetiology and prevention of sports injuries. A review of concepts. Sports Med. 1992;14(2):82\u201399.","journal-title":"Sports Med"},{"issue":"10137","key":"880_CR12","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/S0140-6736(18)30480-X","volume":"391","author":"J Hartvigsen","year":"2018","unstructured":"Hartvigsen J, et al. What low back pain is and why we need to pay attention. Lancet. 2018;391(10137):2356\u201367.","journal-title":"Lancet"},{"issue":"2","key":"880_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s40122-026-00818-x","volume":"15","author":"MAA Moncada","year":"2026","unstructured":"Moncada MAA, et al. Immuno-inflammatory mechanisms in the chronification of pain. Pain Ther. 2026;15(2):443\u201364.","journal-title":"Pain Ther"},{"issue":"2","key":"880_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","volume":"20","author":"T Gong","year":"2020","unstructured":"Gong T, et al. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol. 2020;20(2):95\u2013112.","journal-title":"Nat Rev Immunol"},{"key":"880_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","volume":"4","author":"C Baethge","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4:5.","journal-title":"Res Integr Peer Rev"},{"issue":"10182","key":"880_CR16","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","volume":"393","author":"DJ Hunter","year":"2019","unstructured":"Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745\u201359.","journal-title":"Lancet"},{"issue":"8","key":"880_CR17","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.joca.2009.03.002","volume":"17","author":"RF Loeser","year":"2009","unstructured":"Loeser RF. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage. 2009;17(8):971\u20139.","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"880_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.joca.2012.11.012","volume":"21","author":"F Berenbaum","year":"2013","unstructured":"Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage. 2013;21(1):16\u201321.","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"880_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.bone.2012.02.012","volume":"51","author":"CR Scanzello","year":"2012","unstructured":"Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51(2):249\u201357.","journal-title":"Bone"},{"issue":"1","key":"880_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","volume":"7","author":"M Kapoor","year":"2011","unstructured":"Kapoor M, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7(1):33\u201342.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"880_CR21","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.bbadis.2016.01.003","volume":"1862","author":"P Lepetsos","year":"2016","unstructured":"Lepetsos P, Papavassiliou AG. ROS\/oxidative stress signaling in osteoarthritis. Biochim Biophys Acta. 2016;1862(4):576\u201391.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"880_CR22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/BOR.0b013e328349c2b1","volume":"23","author":"MB Goldring","year":"2011","unstructured":"Goldring MB, Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol. 2011;23(5):471\u20138.","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"880_CR23","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.joca.2018.02.901","volume":"26","author":"MJ McAllister","year":"2018","unstructured":"McAllister MJ, et al. NLRP3 as a potentially novel biomarker for the management of osteoarthritis. Osteoarthritis Cartilage. 2018;26(5):612\u20139.","journal-title":"Osteoarthritis Cartilage"},{"key":"880_CR24","doi-asserted-by":"publisher","first-page":"D713","DOI":"10.2741\/Homandberg","volume":"4","author":"GA Homandberg","year":"1999","unstructured":"Homandberg GA. Potential regulation of cartilage metabolism in osteoarthritis by fibronectin fragments. Front Biosci. 1999;4:D713-30.","journal-title":"Front Biosci"},{"issue":"5","key":"880_CR25","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/art.34315","volume":"64","author":"PL van Lent","year":"2012","unstructured":"van Lent PL, et al. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis Rheum. 2012;64(5):1466\u201376.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"880_CR26","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.bcp.2010.04.024","volume":"80","author":"GM Campo","year":"2010","unstructured":"Campo GM, et al. Small hyaluronan oligosaccharides induce inflammation by engaging both toll-like-4 and CD44 receptors in human chondrocytes. Biochem Pharmacol. 2010;80(4):480\u201390.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"880_CR27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nri.2017.21","volume":"17","author":"AP West","year":"2017","unstructured":"West AP, Shadel GS. Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat Rev Immunol. 2017;17(6):363\u201375.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"880_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s13238-015-0222-9","volume":"7","author":"C Fang","year":"2016","unstructured":"Fang C, Wei X, Wei Y. Mitochondrial DNA in the regulation of innate immune responses. Protein Cell. 2016;7(1):11\u20136.","journal-title":"Protein Cell"},{"issue":"3","key":"880_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/ni.1980","volume":"12","author":"K Nakahira","year":"2011","unstructured":"Nakahira K, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol. 2011;12(3):222\u201330.","journal-title":"Nat Immunol"},{"issue":"1","key":"880_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41413-025-00460-x","volume":"13","author":"S Tan","year":"2025","unstructured":"Tan S, et al. The impact of mitochondrial dysfunction on osteoarthritis cartilage: current insights and emerging mitochondria-targeted therapies. Bone Res. 2025;13(1):77.","journal-title":"Bone Res"},{"issue":"12","key":"880_CR31","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.joca.2016.06.020","volume":"24","author":"T Hawellek","year":"2016","unstructured":"Hawellek T, et al. Articular cartilage calcification of the hip and knee is highly prevalent, independent of age but associated with histological osteoarthritis: evidence for a systemic disorder. Osteoarthritis Cartil. 2016;24(12):2092\u20139.","journal-title":"Osteoarthritis Cartil"},{"issue":"9","key":"880_CR32","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1002\/art.24774","volume":"60","author":"M Fuerst","year":"2009","unstructured":"Fuerst M, et al. Calcification of articular cartilage in human osteoarthritis. Arthritis Rheum. 2009;60(9):2694\u2013703.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"880_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/art.27761","volume":"63","author":"HK Ea","year":"2011","unstructured":"Ea HK, et al. Articular cartilage calcification in osteoarthritis: insights into crystal-induced stress. Arthritis Rheum. 2011;63(1):10\u20138.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"880_CR34","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s00256-025-04904-7","volume":"54","author":"CT Nielsen","year":"2025","unstructured":"Nielsen CT, et al. The association between articular calcium crystal deposition and knee osteoarthritis, joint pain and inflammation: a cross-sectional study. Skeletal Radiol. 2025;54(9):1939\u201347.","journal-title":"Skeletal Radiol"},{"key":"880_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051109","author":"MA Terkawi","year":"2022","unstructured":"Terkawi MA, et al. Low-grade inflammation in the pathogenesis of osteoarthritis: cellular and molecular mechanisms and strategies for future therapeutic intervention. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10051109.","journal-title":"Biomedicines"},{"issue":"10","key":"880_CR36","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","volume":"12","author":"WH Robinson","year":"2016","unstructured":"Robinson WH, et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(10):580\u201392.","journal-title":"Nat Rev Rheumatol"},{"issue":"34","key":"880_CR37","doi-asserted-by":"publisher","first-page":"35719","DOI":"10.1074\/jbc.M403406200","volume":"279","author":"PM Reuben","year":"2004","unstructured":"Reuben PM, Sun Y, Cheung HS. Basic calcium phosphate crystals activate p44\/42 MAPK signal transduction pathway via protein kinase Cmicro in human fibroblasts. J Biol Chem. 2004;279(34):35719\u201325.","journal-title":"J Biol Chem"},{"issue":"4","key":"880_CR38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/ard.60.4.399","volume":"60","author":"GM McCarthy","year":"2001","unstructured":"McCarthy GM, et al. Basic calcium phosphate crystals activate human osteoarthritic synovial fibroblasts and induce matrix metalloproteinase-13 (collagenase-3) in adult porcine articular chondrocytes. Ann Rheum Dis. 2001;60(4):399\u2013406.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"880_CR39","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.bbrc.2007.01.177","volume":"355","author":"ML Major","year":"2007","unstructured":"Major ML, Cheung HS, Misra RP. Basic calcium phosphate crystals activate c-fos expression through a Ras\/ERK dependent signaling mechanism. Biochem Biophys Res Commun. 2007;355(3):654\u201360.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"880_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11926-013-0323-5","volume":"15","author":"R Liu-Bryan","year":"2013","unstructured":"Liu-Bryan R. Synovium and the innate inflammatory network in osteoarthritis progression. Curr Rheumatol Rep. 2013;15(5):323.","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"880_CR41","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.surge.2017.05.005","volume":"15","author":"BJF Dean","year":"2017","unstructured":"Dean BJF, et al. Review: emerging concepts in the pathogenesis of tendinopathy. Surgeon (Lond). 2017;15(6):349\u201354.","journal-title":"Surgeon (Lond)"},{"issue":"3\u20134","key":"880_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.vetimm.2014.01.007","volume":"158","author":"SG Dakin","year":"2014","unstructured":"Dakin SG, Dudhia J, Smith RK. Resolving an inflammatory concept: the importance of inflammation and resolution in tendinopathy. Vet Immunol Immunopathol. 2014;158(3\u20134):121\u20137.","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"880_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13075-016-1218-4","volume":"19","author":"SG Dakin","year":"2017","unstructured":"Dakin SG, et al. Persistent stromal fibroblast activation is present in chronic tendinopathy. Arthritis Res Ther. 2017;19(1):16.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"880_CR44","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/bjsports-2015-094754","volume":"50","author":"BJ Dean","year":"2016","unstructured":"Dean BJ, et al. Are inflammatory cells increased in painful human tendinopathy? A systematic review. Br J Sports Med. 2016;50(4):216\u201320.","journal-title":"Br J Sports Med"},{"issue":"2","key":"880_CR45","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nrrheum.2016.213","volume":"13","author":"NL Millar","year":"2017","unstructured":"Millar NL, Murrell GA, McInnes IB. Inflammatory mechanisms in tendinopathy\u2013towards translation. Nat Rev Rheumatol. 2017;13(2):110\u201322.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"880_CR46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/ncprheum0700","volume":"4","author":"G Riley","year":"2008","unstructured":"Riley G. Tendinopathy\u2013from basic science to treatment. Nat Clin Pract Rheumatol. 2008;4(2):82\u20139.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"1","key":"880_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-020-00234-1","volume":"7","author":"NL Millar","year":"2021","unstructured":"Millar NL, et al. Tendinopathy. Nat Rev Dis Primers. 2021;7(1):1.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"880_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrrheum.2013.160","volume":"10","author":"MV Risbud","year":"2014","unstructured":"Risbud MV, Shapiro IM. Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol. 2014;10(1):44\u201356.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"880_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10180","volume":"3","author":"K Fujii","year":"2019","unstructured":"Fujii K, et al. Discogenic back pain: literature review of definition, diagnosis, and treatment. JBMR Plus. 2019;3(5):e10180.","journal-title":"JBMR Plus"},{"issue":"3","key":"880_CR50","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/00000542-200703000-00024","volume":"106","author":"SP Cohen","year":"2007","unstructured":"Cohen SP, Raja SN. Pathogenesis, diagnosis, and treatment of lumbar zygapophysial (facet) joint pain. Anesthesiology. 2007;106(3):591\u2013614.","journal-title":"Anesthesiology"},{"issue":"1","key":"880_CR51","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mehy.2006.06.033","volume":"68","author":"HM Langevin","year":"2007","unstructured":"Langevin HM, Sherman KJ. Pathophysiological model for chronic low back pain integrating connective tissue and nervous system mechanisms. Med Hypotheses. 2007;68(1):74\u201380.","journal-title":"Med Hypotheses"},{"issue":"1","key":"880_CR52","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1186\/s12891-022-05572-7","volume":"23","author":"B Anderson","year":"2022","unstructured":"Anderson B, et al. Paraspinal muscle health is related to fibrogenic, adipogenic, and myogenic gene expression in patients with lumbar spine pathology. BMC Musculoskelet Disord. 2022;23(1):608.","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"880_CR53","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.math.2009.12.001","volume":"15","author":"J Nijs","year":"2010","unstructured":"Nijs J, Van Houdenhove B, Oostendorp RA. Recognition of central sensitization in patients with musculoskeletal pain: Application of pain neurophysiology in manual therapy practice. Man Ther. 2010;15(2):135\u201341.","journal-title":"Man Ther"},{"issue":"4","key":"880_CR54","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3174\/ajnr.A4173","volume":"36","author":"W Brinjikji","year":"2015","unstructured":"Brinjikji W, et al. Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR Am J Neuroradiol. 2015;36(4):811\u20136.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10","key":"880_CR55","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.jbiomech.2005.03.028","volume":"38","author":"MA Adams","year":"2005","unstructured":"Adams MA, Dolan P. Spine biomechanics. J Biomech. 2005;38(10):1972\u201383.","journal-title":"J Biomech"},{"issue":"2","key":"880_CR56","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1302\/0301-620X.84B2.0840196","volume":"84","author":"JG Burke","year":"2002","unstructured":"Burke JG, et al. Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br. 2002;84(2):196\u2013201.","journal-title":"J Bone Joint Surg Br"},{"issue":"1","key":"880_CR57","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1177\/0363546516643716","volume":"45","author":"J Fitzpatrick","year":"2017","unstructured":"Fitzpatrick J, Bulsara M, Zheng MH. The effectiveness of platelet-rich plasma in the treatment of tendinopathy: a meta-analysis of randomized controlled clinical trials. Am J Sports Med. 2017;45(1):226\u201333.","journal-title":"Am J Sports Med"},{"issue":"1","key":"880_CR58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1172\/JCI11837","volume":"107","author":"G Zhang","year":"2001","unstructured":"Zhang G, Ghosh S. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest. 2001;107(1):13\u20139.","journal-title":"J Clin Invest"},{"issue":"1","key":"880_CR59","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12967-023-04266-5","volume":"21","author":"P Lu","year":"2023","unstructured":"Lu P, et al. Mitochondrial DNA induces nucleus pulposus cell pyroptosis via the TLR9-NF-kappaB-NLRP3 axis. J Transl Med. 2023;21(1):389.","journal-title":"J Transl Med"},{"key":"880_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073069","author":"X Wen","year":"2025","unstructured":"Wen X, et al. Mitochondrial DNA in exercise-mediated innate immune responses. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26073069.","journal-title":"Int J Mol Sci"},{"key":"880_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2022.852249","volume":"3","author":"NDR Ferreira","year":"2022","unstructured":"Ferreira NDR, et al. Action of hyaluronic acid as a damage-associated molecular pattern molecule and its function on the treatment of temporomandibular disorders. Front Pain Res (Lausanne). 2022;3:852249.","journal-title":"Front Pain Res (Lausanne)"},{"key":"880_CR62","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3109\/17453679509157660","volume":"266","author":"MW Lark","year":"1995","unstructured":"Lark MW, Bayne EK, Lohmander LS. Aggrecan degradation in osteoarthritis and rheumatoid arthritis. Acta Orthop Scand Suppl. 1995;266:92\u20137.","journal-title":"Acta Orthop Scand Suppl"},{"key":"880_CR63","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.95704","author":"RE Miller","year":"2018","unstructured":"Miller RE, et al. An aggrecan fragment drives osteoarthritis pain through Toll-like receptor 2. JCI Insight. 2018. https:\/\/doi.org\/10.1172\/jci.insight.95704.","journal-title":"JCI Insight"},{"issue":"2","key":"880_CR64","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/1529-0131(200002)43:2<281::AID-ANR7>3.0.CO;2-7","volume":"43","author":"DH Manicourt","year":"2000","unstructured":"Manicourt DH, et al. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthritis Rheum. 2000;43(2):281\u20138.","journal-title":"Arthritis Rheum"},{"key":"880_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1663547","volume":"16","author":"S Acter","year":"2025","unstructured":"Acter S, Lin Q. S100 proteins as a key immunoregulatory mechanism for NLRP3 inflammasome. Front Immunol. 2025;16:1663547.","journal-title":"Front Immunol"},{"key":"880_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512143","author":"A Palumbo","year":"2023","unstructured":"Palumbo A, et al. The role of alarmins in osteoarthritis pathogenesis: HMGB1, S100B and IL-33. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241512143.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"880_CR67","doi-asserted-by":"publisher","first-page":"17184","DOI":"10.1038\/s41598-017-17472-1","volume":"7","author":"E Krock","year":"2017","unstructured":"Krock E, et al. Toll-like receptor activation induces degeneration of human intervertebral discs. Sci Rep. 2017;7(1):17184.","journal-title":"Sci Rep"},{"issue":"4","key":"880_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/jsp2.1233","volume":"5","author":"C Song","year":"2022","unstructured":"Song C, et al. An in-depth analysis of the immunomodulatory mechanisms of intervertebral disc degeneration. JOR Spine. 2022;5(4):e1233.","journal-title":"JOR Spine"},{"key":"880_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.678757","volume":"12","author":"A Thomson","year":"2021","unstructured":"Thomson A, Hilkens CMU. Synovial macrophages in osteoarthritis: the key to understanding pathogenesis? Front Immunol. 2021;12:678757.","journal-title":"Front Immunol"},{"key":"880_CR70","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/bs.ai.2019.08.006","volume":"143","author":"S Culemann","year":"2019","unstructured":"Culemann S, Gruneboom A, Kronke G. Origin and function of synovial macrophage subsets during inflammatory joint disease. Adv Immunol. 2019;143:75\u201398.","journal-title":"Adv Immunol"},{"key":"880_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1169560","volume":"14","author":"G Koncz","year":"2023","unstructured":"Koncz G, et al. Damage-mediated macrophage polarization in sterile inflammation. Front Immunol. 2023;14:1169560.","journal-title":"Front Immunol"},{"issue":"1","key":"880_CR72","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41392-025-02124-y","volume":"10","author":"F Guan","year":"2025","unstructured":"Guan F, et al. Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets. Signal Transduct Target Ther. 2025;10(1):93.","journal-title":"Signal Transduct Target Ther"},{"key":"880_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076112","author":"K Warmink","year":"2023","unstructured":"Warmink K, et al. Macrophage-driven inflammation in metabolic osteoarthritis: implications for biomarker and therapy development. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24076112.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"880_CR74","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41584-025-01279-w","volume":"21","author":"M Cutolo","year":"2025","unstructured":"Cutolo M, et al. Dynamic macrophage phenotypes in autoimmune and inflammatory rheumatic diseases. Nat Rev Rheumatol. 2025;21(9):546\u201365.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"880_CR75","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.4049\/jimmunol.1300613","volume":"192","author":"A Das","year":"2014","unstructured":"Das A, et al. Engulfment of apoptotic cells by macrophages: a role of microRNA-21 in the resolution of wound inflammation. J Immunol. 2014;192(3):1120\u20139.","journal-title":"J Immunol"},{"issue":"3","key":"880_CR76","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2249.2005.02934.x","volume":"142","author":"F Porcheray","year":"2005","unstructured":"Porcheray F, et al. Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol. 2005;142(3):481\u20139.","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"880_CR77","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1016\/j.ajpath.2015.06.001","volume":"185","author":"A Das","year":"2015","unstructured":"Das A, et al. Monocyte and macrophage plasticity in tissue repair and regeneration. Am J Pathol. 2015;185(10):2596\u2013606.","journal-title":"Am J Pathol"},{"issue":"3","key":"880_CR78","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.4049\/jimmunol.1102310","volume":"188","author":"NK Banda","year":"2012","unstructured":"Banda NK, et al. Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice. J Immunol. 2012;188(3):1469\u201378.","journal-title":"J Immunol"},{"key":"880_CR79","doi-asserted-by":"publisher","first-page":"117954411775143","DOI":"10.1177\/1179544117751430","volume":"11","author":"S Silawal","year":"2018","unstructured":"Silawal S, et al. Osteoarthritis and the Complement Cascade. Clin Med Insights Arthritis Musculoskelet Disord. 2018;11:1179544117751430.","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"issue":"7","key":"880_CR80","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.joca.2015.03.019","volume":"23","author":"MJ Peffers","year":"2015","unstructured":"Peffers MJ, et al. Comprehensive protein profiling of synovial fluid in osteoarthritis following protein equalization. Osteoarthritis Cartilage. 2015;23(7):1204\u201313.","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"880_CR81","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13075-016-1123-x","volume":"18","author":"A Struglics","year":"2016","unstructured":"Struglics A, et al. The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis. Arthritis Res Ther. 2016;18(1):223.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"880_CR82","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1038\/nm.2543","volume":"17","author":"Q Wang","year":"2011","unstructured":"Wang Q, et al. Identification of a central role for complement in osteoarthritis. Nat Med. 2011;17(12):1674\u20139.","journal-title":"Nat Med"},{"key":"880_CR83","doi-asserted-by":"publisher","first-page":"15671","DOI":"10.2147\/JIR.S563253","volume":"18","author":"P Wen","year":"2025","unstructured":"Wen P, Liu L. Functions of macrophages, T cells, and neutrophils in the synovial microenvironment of osteoarthritis. J Inflamm Res. 2025;18:15671\u201386.","journal-title":"J Inflamm Res"},{"issue":"2","key":"880_CR84","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/ar4545","volume":"16","author":"B Moradi","year":"2014","unstructured":"Moradi B, et al. CD4(+)CD25(+)\/highCD127low\/(-) regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints\u2013analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood. Arthritis Res Ther. 2014;16(2):R97.","journal-title":"Arthritis Res Ther"},{"key":"880_CR85","first-page":"356","volume":"8","author":"YS Li","year":"2017","unstructured":"Li YS, et al. T cells in osteoarthritis: alterations and beyond. Front Immunol. 2017;8:356.","journal-title":"Front Immunol"},{"key":"880_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107781","volume":"96","author":"L Lei","year":"2021","unstructured":"Lei L, et al. Interleukin-17 induces pyroptosis in osteoblasts through the NLRP3 inflammasome pathway in vitro. Int Immunopharmacol. 2021;96:107781.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"880_CR87","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jaci.2022.02.031","volume":"150","author":"Y Li","year":"2022","unstructured":"Li Y, et al. IL-17A mediates pyroptosis via the ERK pathway and contributes to steroid resistance in CRSwNP. J Allergy Clin Immunol. 2022;150(2):337\u201351.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"880_CR88","doi-asserted-by":"publisher","first-page":"674","DOI":"10.21037\/atm-19-1739","volume":"8","author":"LL Li","year":"2020","unstructured":"Li LL, et al. The activation of IL-17 signaling pathway promotes pyroptosis in pneumonia-induced sepsis. Ann Transl Med. 2020;8(11):674.","journal-title":"Ann Transl Med"},{"key":"880_CR89","doi-asserted-by":"publisher","first-page":"39","DOI":"10.22203\/eCM.v043a05","volume":"43","author":"G Crosio","year":"2022","unstructured":"Crosio G, Huang AH. Innate and adaptive immune system cells implicated in tendon healing and disease. Eur Cell Mater. 2022;43:39\u201352.","journal-title":"Eur Cell Mater"},{"issue":"3","key":"880_CR90","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1152\/japplphysiol.00682.2019","volume":"128","author":"AC Noah","year":"1985","unstructured":"Noah AC, et al. Adaptive and innate immune cell responses in tendons and lymph nodes after tendon injury and repair. J Appl Physiol. 1985;128(3):473\u201382.","journal-title":"J Appl Physiol"},{"issue":"8","key":"880_CR91","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1136\/annrheumdis-2020-219335","volume":"80","author":"E Garcia-Melchor","year":"2021","unstructured":"Garcia-Melchor E, et al. Novel self-amplificatory loop between T cells and tenocytes as a driver of chronicity in tendon disease. Ann Rheum Dis. 2021;80(8):1075\u201385.","journal-title":"Ann Rheum Dis"},{"key":"880_CR92","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2147\/ITT.S499605","volume":"14","author":"A Berbudi","year":"2025","unstructured":"Berbudi A, Khairani S, Tjahjadi AI. Interplay between insulin resistance and immune dysregulation in type 2 diabetes mellitus: implications for therapeutic interventions. Immunotargets Ther. 2025;14:359\u201382.","journal-title":"Immunotargets Ther"},{"issue":"2","key":"880_CR93","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/j.2040-4603.2012.tb00425.x","volume":"2","author":"FW Booth","year":"2012","unstructured":"Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic diseases. Compr Physiol. 2012;2(2):1143\u2013211.","journal-title":"Compr Physiol"},{"issue":"4","key":"880_CR94","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1600-0838.2009.00986.x","volume":"19","author":"M Kjaer","year":"2009","unstructured":"Kjaer M, et al. From mechanical loading to collagen synthesis, structural changes and function in human tendon. Scand J Med Sci Sports. 2009;19(4):500\u201310.","journal-title":"Scand J Med Sci Sports"},{"issue":"2","key":"880_CR95","first-page":"115","volume":"11","author":"KM Heinemeier","year":"2011","unstructured":"Heinemeier KM, Kjaer M. In vivo investigation of tendon responses to mechanical loading. J Musculoskelet Neuronal Interact. 2011;11(2):115\u201323.","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"3","key":"880_CR96","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/ar629","volume":"5","author":"JP Urban","year":"2003","unstructured":"Urban JP, Roberts S. Degeneration of the intervertebral disc. Arthritis Res Ther. 2003;5(3):120\u201330.","journal-title":"Arthritis Res Ther"},{"key":"880_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiomech.2019.109573","volume":"102","author":"JPG Urban","year":"2020","unstructured":"Urban JPG, Fairbank JCT. Current perspectives on the role of biomechanical loading and genetics in development of disc degeneration and low back pain; a narrative review. J Biomech. 2020;102:109573.","journal-title":"J Biomech"},{"issue":"5","key":"880_CR98","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nrrheum.2010.43","volume":"6","author":"SP Magnusson","year":"2010","unstructured":"Magnusson SP, Langberg H, Kjaer M. The pathogenesis of tendinopathy: balancing the response to loading. Nat Rev Rheumatol. 2010;6(5):262\u20138.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"880_CR99","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/mus.26702","volume":"60","author":"PA Leermakers","year":"2019","unstructured":"Leermakers PA, et al. Skeletal muscle unloading results in increased mitophagy and decreased mitochondrial biogenesis regulation. Muscle Nerve. 2019;60(6):769\u201378.","journal-title":"Muscle Nerve"},{"key":"880_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01307","volume":"9","author":"LG Leal","year":"2018","unstructured":"Leal LG, Lopes MA, Batista ML Jr. Physical exercise-induced myokines and muscle-adipose tissue crosstalk: a review of current knowledge and the implications for health and metabolic diseases. Front Physiol. 2018;9:1307.","journal-title":"Front Physiol"},{"key":"880_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/biom14101205","author":"Z Lu","year":"2024","unstructured":"Lu Z, et al. Myokines may be the answer to the beneficial immunomodulation of tailored exercise-a narrative review. Biomolecules. 2024. https:\/\/doi.org\/10.3390\/biom14101205.","journal-title":"Biomolecules"},{"key":"880_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/jfmk7040076","author":"E Teixeira","year":"2022","unstructured":"Teixeira E, et al. Sedentary behaviour impairs skeletal muscle repair modulating the inflammatory response. J Funct Morphol Kinesiol. 2022. https:\/\/doi.org\/10.3390\/jfmk7040076.","journal-title":"J Funct Morphol Kinesiol"},{"key":"880_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111676","volume":"552","author":"JJ Slate-Romano","year":"2022","unstructured":"Slate-Romano JJ, Yano N, Zhao TC. Irisin reduces inflammatory signaling pathways in inflammation-mediated metabolic syndrome. Mol Cell Endocrinol. 2022;552:111676.","journal-title":"Mol Cell Endocrinol"},{"issue":"7640","key":"880_CR104","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177\u201385.","journal-title":"Nature"},{"issue":"4","key":"880_CR105","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/rheumatology\/kes395","volume":"52","author":"M Abate","year":"2013","unstructured":"Abate M, et al. Occurrence of tendon pathologies in metabolic disorders. Rheumatology (Oxford). 2013;52(4):599\u2013608.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"880_CR106","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrrheum.2010.159","volume":"6","author":"J Sellam","year":"2010","unstructured":"Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. 2010;6(11):625\u201335.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"880_CR107","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/bmb\/ldz040","volume":"133","author":"E Chisari","year":"2020","unstructured":"Chisari E, et al. The role of the immune system in tendon healing: a systematic review. Br Med Bull. 2020;133(1):49\u201364.","journal-title":"Br Med Bull"},{"issue":"4","key":"880_CR108","doi-asserted-by":"publisher","first-page":"C1081","DOI":"10.1152\/ajpcell.00072.2026","volume":"330","author":"ZJ Chafouleas","year":"2026","unstructured":"Chafouleas ZJ, et al. The cellular basis of fibrotic tendon healing: now in higher definition. Am J Physiol Cell Physiol. 2026;330(4):C1081\u201392.","journal-title":"Am J Physiol Cell Physiol"},{"key":"880_CR109","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.trsl.2019.02.002","volume":"209","author":"AEC Nichols","year":"2019","unstructured":"Nichols AEC, Best KT, Loiselle AE. The cellular basis of fibrotic tendon healing: challenges and opportunities. Transl Res. 2019;209:156\u201368.","journal-title":"Transl Res"},{"key":"880_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147299","author":"DM Klyne","year":"2021","unstructured":"Klyne DM, et al. Does the interaction between local and systemic inflammation provide a link from psychology and lifestyle to tissue health in musculoskeletal conditions? Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22147299.","journal-title":"Int J Mol Sci"},{"key":"880_CR111","doi-asserted-by":"crossref","unstructured":"Michalaki E et al. Effect of human synovial fluid from osteoarthritis patients and healthy individuals on lymphatic contractile activity. J Biomech Eng. 2022;144(7).","DOI":"10.1115\/1.4053749"},{"key":"880_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1671502","volume":"17","author":"Y Li","year":"2026","unstructured":"Li Y, et al. Mitochondrial quality control modulating chondrocyte behavior and fate in knee osteoarthritis: mechanistic insights and therapeutic prospects. Front Immunol. 2026;17:1671502.","journal-title":"Front Immunol"},{"issue":"1","key":"880_CR113","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.joca.2012.09.012","volume":"21","author":"DT Felson","year":"2013","unstructured":"Felson DT. Osteoarthritis as a disease of mechanics. Osteoarthritis Cartilage. 2013;21(1):10\u20135.","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"880_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbm.2025.100164","volume":"3","author":"G Wu","year":"2025","unstructured":"Wu G, et al. Mechanical cues enhance chondrocyte function: insights from mechanoreception, regulation, and biological responses. Mechanobiol Med. 2025;3(4):100164.","journal-title":"Mechanobiol Med"},{"issue":"11","key":"880_CR115","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2519\/jospt.2015.5884","volume":"45","author":"A Scott","year":"2015","unstructured":"Scott A, Backman LJ, Speed C. Tendinopathy: update on pathophysiology. J Orthop Sports Phys Ther. 2015;45(11):833\u201341.","journal-title":"J Orthop Sports Phys Ther"},{"issue":"4","key":"880_CR116","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/bjsm.2008.054239","volume":"43","author":"KM Khan","year":"2009","unstructured":"Khan KM, Scott A. Mechanotherapy: how physical therapists\u2019 prescription of exercise promotes tissue repair. Br J Sports Med. 2009;43(4):247\u201352.","journal-title":"Br J Sports Med"},{"issue":"1","key":"880_CR117","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40279-013-0096-z","volume":"44","author":"E Rio","year":"2014","unstructured":"Rio E, et al. The pain of tendinopathy: physiological or pathophysiological? Sports Med. 2014;44(1):9\u201323.","journal-title":"Sports Med"},{"issue":"11","key":"880_CR118","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1002\/art.21415","volume":"52","author":"EM Roos","year":"2005","unstructured":"Roos EM, Dahlberg L. Positive effects of moderate exercise on glycosaminoglycan content in knee cartilage: a four-month, randomized, controlled trial in patients at risk of osteoarthritis. Arthritis Rheum. 2005;52(11):3507\u201314.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"880_CR119","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/sms.12491","volume":"26","author":"SI Docking","year":"2016","unstructured":"Docking SI, Cook J. Pathological tendons maintain sufficient aligned fibrillar structure on ultrasound tissue characterization (UTC). Scand J Med Sci Sports. 2016;26(6):675\u201383.","journal-title":"Scand J Med Sci Sports"},{"issue":"4","key":"880_CR120","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41584-019-0364-x","volume":"16","author":"E Gracey","year":"2020","unstructured":"Gracey E, et al. Tendon and ligament mechanical loading in the pathogenesis of inflammatory arthritis. Nat Rev Rheumatol. 2020;16(4):193\u2013207.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"880_CR121","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/JSM.0000000000000364","volume":"27","author":"E Rio","year":"2017","unstructured":"Rio E, et al. Isometric contractions are more analgesic than isotonic contractions for patellar tendon pain: an in-season randomized clinical trial. Clin J Sport Med. 2017;27(3):253\u20139.","journal-title":"Clin J Sport Med"},{"key":"880_CR122","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/1471-2474-15-386","volume":"15","author":"E Huisman","year":"2014","unstructured":"Huisman E, et al. Enhanced collagen type I synthesis by human tenocytes subjected to periodic in vitro mechanical stimulation. BMC Musculoskelet Disord. 2014;15:386.","journal-title":"BMC Musculoskelet Disord"},{"issue":"4","key":"880_CR123","doi-asserted-by":"publisher","first-page":"482","DOI":"10.4239\/wjd.v5.i4.482","volume":"5","author":"S Larsen","year":"2014","unstructured":"Larsen S, et al. Effects of exercise training on mitochondrial function in patients with type 2 diabetes. World J Diabetes. 2014;5(4):482\u201392.","journal-title":"World J Diabetes"},{"key":"880_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/life11010061","author":"RA Casuso","year":"2021","unstructured":"Casuso RA, Huertas JR. Mitochondrial functionality in inflammatory pathology-modulatory role of physical activity. Life. 2021. https:\/\/doi.org\/10.3390\/life11010061.","journal-title":"Life"},{"key":"880_CR125","doi-asserted-by":"publisher","first-page":"1710264","DOI":"10.3389\/fspor.2026.1710264","volume":"8","author":"Q Wan","year":"2026","unstructured":"Wan Q, et al. Effects of exercise training on skeletal muscle function in patients with mitochondrial myopathy: a systematic review. Front Sports Act Living. 2026;8:1710264.","journal-title":"Front Sports Act Living"},{"issue":"12","key":"880_CR126","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1055\/a-1398-5501","volume":"42","author":"B Bradford","year":"2021","unstructured":"Bradford B, et al. Immediate effects of two isometric calf muscle exercises on mid-portion Achilles tendon pain. Int J Sports Med. 2021;42(12):1122\u20137.","journal-title":"Int J Sports Med"},{"issue":"5","key":"880_CR127","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/ptj\/pzy022","volume":"98","author":"PB O'Sullivan","year":"2018","unstructured":"O\u2019Sullivan PB, et al. Cognitive functional therapy: an integrated behavioral approach for the targeted management of disabling low back pain. Phys Ther. 2018;98(5):408\u201323.","journal-title":"Phys Ther"},{"issue":"5","key":"880_CR128","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","volume":"31","author":"E Ricciotti","year":"2011","unstructured":"Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011;31(5):986\u20131000.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"880_CR129","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00296-011-2263-6","volume":"32","author":"PG Conaghan","year":"2012","unstructured":"Conaghan PG. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol Int. 2012;32(6):1491\u2013502.","journal-title":"Rheumatol Int"},{"key":"880_CR130","doi-asserted-by":"crossref","unstructured":"Crofford LJ. Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther. 2013;15 Suppl 3(Suppl 3):S2.","DOI":"10.1186\/ar4174"},{"issue":"1","key":"880_CR131","doi-asserted-by":"publisher","first-page":"46","DOI":"10.7326\/M14-1231","volume":"162","author":"RR Bannuru","year":"2015","unstructured":"Bannuru RR, et al. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med. 2015;162(1):46\u201354.","journal-title":"Ann Intern Med"},{"key":"880_CR132","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2321","volume":"375","author":"BR da Costa","year":"2021","unstructured":"da Costa BR, et al. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis. BMJ. 2021;375:n2321.","journal-title":"BMJ"},{"issue":"9","key":"880_CR133","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1007\/s11999-013-3010-y","volume":"471","author":"BJ Dean","year":"2013","unstructured":"Dean BJ, Franklin SL, Carr AJ. The peripheral neuronal phenotype is important in the pathogenesis of painful human tendinopathy: a systematic review. Clin Orthop Relat Res. 2013;471(9):3036\u201346.","journal-title":"Clin Orthop Relat Res"},{"issue":"7","key":"880_CR134","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s11999-008-0260-1","volume":"466","author":"BM Andres","year":"2008","unstructured":"Andres BM, Murrell GA. Treatment of tendinopathy: what works, what does not, and what is on the horizon. Clin Orthop Relat Res. 2008;466(7):1539\u201354.","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"880_CR135","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1152\/japplphysiol.00053.2013","volume":"115","author":"B Su","year":"1985","unstructured":"Su B, O\u2019Connor JP. NSAID therapy effects on healing of bone, tendon, and the enthesis. J Appl Physiol. 1985;115(6):892\u20139.","journal-title":"J Appl Physiol"},{"issue":"1","key":"880_CR136","first-page":"23","volume":"1","author":"KM Chan","year":"2009","unstructured":"Chan KM, Fu SC. Anti-inflammatory management for tendon injuries - friends or foes? Sports Med Arthrosc Rehabil Ther Technol. 2009;1(1):23.","journal-title":"Sports Med Arthrosc Rehabil Ther Technol"},{"key":"880_CR137","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.q2030","volume":"386","author":"E Cervoni","year":"2024","unstructured":"Cervoni E. Non-steroidal anti-inflammatory drugs may disrupt muscle and tissue repair. BMJ. 2024;386:q2030.","journal-title":"BMJ"},{"issue":"1","key":"880_CR138","first-page":"107","volume":"39","author":"KR Duchman","year":"2019","unstructured":"Duchman KR, et al. The effect of non-steroidal anti-inflammatory drugs on tendon-to-bone healing: a systematic review with subgroup meta-analysis. Iowa Orthop J. 2019;39(1):107\u201319.","journal-title":"Iowa Orthop J"},{"issue":"12","key":"880_CR139","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.RVW.19.00055","volume":"7","author":"N Ghosh","year":"2019","unstructured":"Ghosh N, et al. Nonsteroidal anti-inflammatory drugs (NSAIDs) and their effect on musculoskeletal soft-tissue healing: a scoping review. JBJS Rev. 2019;7(12):e4.","journal-title":"JBJS Rev"},{"issue":"5","key":"880_CR140","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1152\/japplphysiol.00281.2017","volume":"123","author":"KM Heinemeier","year":"1985","unstructured":"Heinemeier KM, et al. Effects of anti-inflammatory (NSAID) treatment on human tendinopathic tissue. J Appl Physiol. 1985;123(5):1397\u2013405.","journal-title":"J Appl Physiol"},{"issue":"9754","key":"880_CR141","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/S0140-6736(10)61160-9","volume":"376","author":"BK Coombes","year":"2010","unstructured":"Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. 2010;376(9754):1751\u201367.","journal-title":"Lancet"},{"issue":"17","key":"880_CR142","doi-asserted-by":"publisher","first-page":"e758","DOI":"10.5435\/JAAOS-D-18-00106","volume":"27","author":"CL Martin","year":"2019","unstructured":"Martin CL, Browne JA. Intra-articular corticosteroid injections for symptomatic knee osteoarthritis: what the orthopaedic provider needs to know. J Am Acad Orthop Surg. 2019;27(17):e758\u201366.","journal-title":"J Am Acad Orthop Surg"},{"issue":"11","key":"880_CR143","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","volume":"27","author":"RR Bannuru","year":"2019","unstructured":"Bannuru RR, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578\u201389.","journal-title":"Osteoarthritis Cartilage"},{"issue":"9","key":"880_CR144","doi-asserted-by":"publisher","first-page":"e721","DOI":"10.5435\/JAAOS-D-21-01233","volume":"30","author":"RH Brophy","year":"2022","unstructured":"Brophy RH, Fillingham YA. AAOS clinical practice guideline summary: management of osteoarthritis of the knee (nonarthroplasty), third edition. J Am Acad Orthop Surg. 2022;30(9):e721\u20139.","journal-title":"J Am Acad Orthop Surg"},{"issue":"2","key":"880_CR145","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/art.41142","volume":"72","author":"SL Kolasinski","year":"2020","unstructured":"Kolasinski SL, et al. 2019 American College of Rheumatology\/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020;72(2):220\u201333.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"880_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.ocarto.2021.100232","volume":"4","author":"M Sabha","year":"2022","unstructured":"Sabha M, Hochberg MC. Non-surgical management of hip and knee osteoarthritis; comparison of ACR\/AF and OARSI 2019 and VA\/DoD 2020 guidelines. Osteoarthr Cartil Open. 2022;4(1):100232.","journal-title":"Osteoarthr Cartil Open"},{"key":"880_CR147","first-page":"3","volume":"39","author":"EA Balazs","year":"1993","unstructured":"Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993;39:3\u20139.","journal-title":"J Rheumatol Suppl"},{"issue":"3","key":"880_CR148","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2478\/intox-2013-0019","volume":"6","author":"TM Tamer","year":"2013","unstructured":"Tamer TM. Hyaluronan and synovial joint: function, distribution and healing. Interdiscip Toxicol. 2013;6(3):111\u201325.","journal-title":"Interdiscip Toxicol"},{"issue":"6","key":"880_CR149","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S0736-0266(02)00050-5","volume":"20","author":"D Mazzucco","year":"2002","unstructured":"Mazzucco D, et al. Rheology of joint fluid in total knee arthroplasty patients. J Orthop Res. 2002;20(6):1157\u201363.","journal-title":"J Orthop Res"},{"issue":"2","key":"880_CR150","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/ar623","volume":"5","author":"LW Moreland","year":"2003","unstructured":"Moreland LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther. 2003;5(2):54\u201367.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"880_CR151","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1177\/1947603516662503","volume":"8","author":"AK Bhadra","year":"2017","unstructured":"Bhadra AK, et al. Appropriate use criteria for hyaluronic acid in the treatment of knee osteoarthritis in the United States. Cartilage. 2017;8(3):234\u201354.","journal-title":"Cartilage"},{"issue":"2","key":"880_CR152","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.semarthrit.2015.04.013","volume":"45","author":"RD Altman","year":"2015","unstructured":"Altman RD, Schemitsch E, Bedi A. Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid. Semin Arthritis Rheum. 2015;45(2):132\u20139.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"880_CR153","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.joca.2008.11.013","volume":"17","author":"A Gomis","year":"2009","unstructured":"Gomis A, et al. Intra-articular injections of hyaluronan solutions of different elastoviscosity reduce nociceptive nerve activity in a model of osteoarthritic knee joint of the guinea pig. Osteoarthritis Cartilage. 2009;17(6):798\u2013804.","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"880_CR154","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1254\/fpj.100.359","volume":"100","author":"S Aihara","year":"1992","unstructured":"Aihara S, et al. Effects of sodium hyaluronate on the nociceptive response of rats with experimentally induced arthritis. Nihon Yakurigaku Zasshi. 1992;100(4):359\u201365.","journal-title":"Nihon Yakurigaku Zasshi"},{"key":"880_CR155","doi-asserted-by":"publisher","first-page":"117954411772361","DOI":"10.1177\/1179544117723611","volume":"10","author":"MA Nicholls","year":"2017","unstructured":"Nicholls MA, et al. The disease-modifying effects of Hyaluronan in the osteoarthritic disease state. Clin Med Insights Arthritis Musculoskelet Disord. 2017;10:1179544117723611.","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"issue":"3","key":"880_CR156","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00296-004-0547-9","volume":"26","author":"M Tanaka","year":"2006","unstructured":"Tanaka M, et al. Suppressive effects of hyaluronan on MMP-1 and RANTES production from chondrocytes. Rheumatol Int. 2006;26(3):185\u201390.","journal-title":"Rheumatol Int"},{"issue":"2","key":"880_CR157","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.bbrc.2012.12.003","volume":"430","author":"S Hirabara","year":"2013","unstructured":"Hirabara S, et al. Hyaluronan inhibits TLR-4 dependent cathepsin K and matrix metalloproteinase 1 expression in human fibroblasts. Biochem Biophys Res Commun. 2013;430(2):519\u201322.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"880_CR158","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/jor.20558","volume":"26","author":"Y Mitsui","year":"2008","unstructured":"Mitsui Y, et al. Hyaluronic acid inhibits mRNA expression of proinflammatory cytokines and cyclooxygenase-2\/prostaglandin E(2) production via CD44 in interleukin-1-stimulated subacromial synovial fibroblasts from patients with rotator cuff disease. J Orthop Res. 2008;26(7):1032\u20137.","journal-title":"J Orthop Res"},{"issue":"6","key":"880_CR159","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1136\/ard.2007.086884","volume":"68","author":"T Yatabe","year":"2009","unstructured":"Yatabe T, et al. Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes. Ann Rheum Dis. 2009;68(6):1051\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"880_CR160","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41598-019-57073-8","volume":"10","author":"M Suzuki","year":"2020","unstructured":"Suzuki M, et al. Hyaluronan suppresses enhanced cathepsin K expression via activation of NF-kappaB with mechanical stress loading in a human chondrocytic HCS-2\/8 cells. Sci Rep. 2020;10(1):216.","journal-title":"Sci Rep"},{"issue":"6","key":"880_CR161","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3892\/br.2023.1623","volume":"18","author":"P Charnwichai","year":"2023","unstructured":"Charnwichai P, et al. Histological features of knee osteoarthritis treated with triamcinolone acetonide and hyaluronic acid. Biomed Rep. 2023;18(6):40.","journal-title":"Biomed Rep"},{"issue":"11","key":"880_CR162","volume":"17","author":"OI Oduware","year":"2025","unstructured":"Oduware OI, Ogbemudia AO, Onuminya JE. Efficacy of intra-articular hyaluronic acid and triamcinolone acetonide combination versus hyaluronic acid alone in knee osteoarthritis. Cureus. 2025;17(11):e96129.","journal-title":"Cureus"},{"issue":"2","key":"880_CR163","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s11999-012-2659-y","volume":"471","author":"GC de Campos","year":"2013","unstructured":"de Campos GC, et al. Adding triamcinolone improves viscosupplementation: a randomized clinical trial. Clin Orthop Relat Res. 2013;471(2):613\u201320.","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"880_CR164","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/19417381211073316","volume":"15","author":"M Khan","year":"2023","unstructured":"Khan M, et al. The role of hyaluronic acid for soft tissue indications: a systematic review and meta-analysis. Sports Health. 2023;15(1):86\u201396.","journal-title":"Sports Health"},{"key":"880_CR165","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113081","author":"F Oliva","year":"2021","unstructured":"Oliva F, et al. The impact of hyaluronic acid on tendon physiology and its clinical application in tendinopathies. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10113081.","journal-title":"Cells"},{"key":"880_CR166","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14176291","author":"F Agostini","year":"2025","unstructured":"Agostini F, et al. Effectiveness of ultrasound-guided peritendinous injection treatment with low molecular weight hyaluronic acid in patients with supraspinatus tendinopathy. J Clin Med. 2025. https:\/\/doi.org\/10.3390\/jcm14176291.","journal-title":"J Clin Med"},{"key":"880_CR167","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10071397","author":"M Gervasi","year":"2021","unstructured":"Gervasi M, et al. Treatment of Achilles tendinopathy in recreational runners with peritendinous hyaluronic acid injections: a viscoelastometric, functional, and biochemical pilot study. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10071397.","journal-title":"J Clin Med"},{"issue":"24","key":"880_CR168","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.2106\/JBJS.N.00743","volume":"97","author":"D Jevsevar","year":"2015","unstructured":"Jevsevar D, et al. Viscosupplementation for osteoarthritis of the knee: a systematic review of the evidence. J Bone Joint Surg Am. 2015;97(24):2047\u201360.","journal-title":"J Bone Joint Surg Am"},{"issue":"12","key":"880_CR169","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrrheum.2013.141","volume":"9","author":"I Andia","year":"2013","unstructured":"Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol. 2013;9(12):721\u201330.","journal-title":"Nat Rev Rheumatol"},{"issue":"20","key":"880_CR170","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1001\/jama.2021.19415","volume":"326","author":"KL Bennell","year":"2021","unstructured":"Bennell KL, et al. Effect of intra-articular platelet-rich plasma vs placebo injection on pain and medial tibial cartilage volume in patients with knee osteoarthritis: the RESTORE randomized clinical trial. JAMA. 2021;326(20):2021\u201330.","journal-title":"JAMA"},{"issue":"11\u201312","key":"880_CR171","doi-asserted-by":"publisher","first-page":"e2347","DOI":"10.1093\/milmed\/usae022","volume":"189","author":"E Mende","year":"2024","unstructured":"Mende E, Love RJ, Young JL. A comprehensive summary of the meta-analyses and systematic reviews on platelet-rich plasma therapies for knee osteoarthritis. Mil Med. 2024;189(11\u201312):e2347\u201356.","journal-title":"Mil Med"},{"issue":"1","key":"880_CR172","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1055\/s-0034-1384671","volume":"28","author":"I Andia","year":"2015","unstructured":"Andia I, Maffulli N. Use of platelet-rich plasma for patellar tendon and medial collateral ligament injuries: best current clinical practice. J Knee Surg. 2015;28(1):11\u20138.","journal-title":"J Knee Surg"},{"key":"880_CR173","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207794","author":"P Everts","year":"2020","unstructured":"Everts P, et al. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21207794.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"880_CR174","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1177\/0363546509349921","volume":"37","author":"TE Foster","year":"2009","unstructured":"Foster TE, et al. Platelet-rich plasma from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259\u201372.","journal-title":"Am J Sports Med"},{"issue":"1","key":"880_CR175","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/prd.12537","volume":"94","author":"RJ Miron","year":"2024","unstructured":"Miron RJ, et al. Extended platelet-rich fibrin. Periodontol 2000. 2024;94(1):114\u201330.","journal-title":"Periodontol 2000"},{"issue":"1","key":"880_CR176","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/prd.12521","volume":"94","author":"RJ Miron","year":"2024","unstructured":"Miron RJ, et al. Optimization of platelet-rich fibrin. Periodontol 2000. 2024;94(1):79\u201391.","journal-title":"Periodontol 2000"},{"key":"880_CR177","doi-asserted-by":"publisher","first-page":"8059622","DOI":"10.1155\/2022\/8059622","volume":"2022","author":"M Dejnek","year":"2022","unstructured":"Dejnek M, et al. Leukocyte-rich platelet-rich plasma as an effective source of molecules that modulate local immune and inflammatory cell responses. Oxid Med Cell Longev. 2022;2022:8059622.","journal-title":"Oxid Med Cell Longev"},{"key":"880_CR178","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098358","author":"R Ni","year":"2023","unstructured":"Ni R, et al. Biologic mechanisms of macrophage phenotypes responding to infection and the novel therapies to moderate inflammation. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24098358.","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"880_CR179","first-page":"S13","volume":"105","author":"AT Nurden","year":"2011","unstructured":"Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011;105(Suppl 1):S13-33.","journal-title":"Thromb Haemost"},{"issue":"12","key":"880_CR180","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.4049\/jimmunol.1500259","volume":"194","author":"R Kapur","year":"2015","unstructured":"Kapur R, et al. Nouvelle cuisine: platelets served with inflammation. J Immunol. 2015;194(12):5579\u201387.","journal-title":"J Immunol"},{"issue":"1","key":"880_CR181","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/0363546513507766","volume":"42","author":"EA Sundman","year":"2014","unstructured":"Sundman EA, et al. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med. 2014;42(1):35\u201341.","journal-title":"Am J Sports Med"},{"key":"880_CR182","doi-asserted-by":"crossref","unstructured":"Wu WS, Chen LR, Chen KH. Platelet-rich plasma (PRP): molecular mechanisms, actions and clinical applications in human body. Int J Mol Sci. 2025;26(21).","DOI":"10.3390\/ijms262110804"},{"key":"880_CR183","doi-asserted-by":"crossref","unstructured":"Everts PA et al. Profound properties of protein-rich, platelet-rich plasma matrices as novel, multi-purpose biological platforms in tissue repair, regeneration, and wound healing. Int J Mol Sci. 2024;25(14)","DOI":"10.3390\/ijms25147914"},{"issue":"1","key":"880_CR184","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/jbm.a.36792","volume":"108","author":"J Zhang","year":"2020","unstructured":"Zhang J, et al. Anti-inflammation effects of injectable platelet-rich fibrin via macrophages and dendritic cells. J Biomed Mater Res A. 2020;108(1):61\u20138.","journal-title":"J Biomed Mater Res A"},{"issue":"6","key":"880_CR185","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1177\/0363546512442334","volume":"40","author":"JL Dragoo","year":"2012","unstructured":"Dragoo JL, et al. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med. 2012;40(6):1274\u201381.","journal-title":"Am J Sports Med"},{"key":"880_CR186","doi-asserted-by":"publisher","DOI":"10.1111\/prd.12626","author":"N Farshidfar","year":"2000","unstructured":"Farshidfar N, et al. Platelet-rich plasma (PRP) versus injectable platelet-rich fibrin (i-PRF): a systematic review across all fields of medicine. Periodontol 2000. 2000. https:\/\/doi.org\/10.1111\/prd.12626.","journal-title":"Periodontol 2000"},{"issue":"1","key":"880_CR187","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/ten.teb.2016.0233","volume":"23","author":"RJ Miron","year":"2017","unstructured":"Miron RJ, et al. Platelet-rich fibrin and soft tissue wound healing: a systematic review. Tissue Eng Part B Rev. 2017;23(1):83\u201399.","journal-title":"Tissue Eng Part B Rev"},{"issue":"9","key":"880_CR188","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1007\/s00784-016-1719-1","volume":"20","author":"E Kobayashi","year":"2016","unstructured":"Kobayashi E, et al. Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Investig. 2016;20(9):2353\u201360.","journal-title":"Clin Oral Investig"},{"key":"880_CR189","doi-asserted-by":"publisher","DOI":"10.3390\/cells12040634","author":"Z Kargarpour","year":"2023","unstructured":"Kargarpour Z, et al. Lipids of platelet-rich fibrin reduce the inflammatory response in mesenchymal cells and macrophages. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12040634.","journal-title":"Cells"},{"key":"880_CR190","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111333","author":"Z Kargarpour","year":"2021","unstructured":"Kargarpour Z, et al. Platelet-rich fibrin decreases the inflammatory response of mesenchymal cells. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222111333.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"880_CR191","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1007\/s11999-015-4179-z","volume":"473","author":"I Andia","year":"2015","unstructured":"Andia I, Rubio-Azpeitia E, Maffulli N. Platelet-rich plasma modulates the secretion of inflammatory\/angiogenic proteins by inflamed tenocytes. Clin Orthop Relat Res. 2015;473(5):1624\u201334.","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"880_CR192","first-page":"533","volume":"12","author":"G Filardo","year":"2014","unstructured":"Filardo G, et al. Platelet-rich plasma injections for the treatment of refractory Achilles tendinopathy: results at 4 years. Blood Transfus. 2014;12(4):533\u201340.","journal-title":"Blood Transfus"},{"issue":"75","key":"880_CR193","doi-asserted-by":"publisher","first-page":"332","DOI":"10.15557\/JoU.2018.0048","volume":"18","author":"M Ali","year":"2018","unstructured":"Ali M, et al. The use of ultrasound-guided platelet-rich plasma injections in the treatment of hip osteoarthritis: a systematic review of the literature. J Ultrason. 2018;18(75):332\u20137.","journal-title":"J Ultrason"},{"key":"880_CR194","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1007\/s00167-019-05763-1","volume":"28","author":"M Phillips","year":"2020","unstructured":"Phillips M, et al. Differentiating factors of intra-articular injectables have a meaningful impact on knee osteoarthritis outcomes: a network meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2020;28:3031\u20139.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"5","key":"880_CR195","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/bjsports-2020-102179","volume":"55","author":"A Gazendam","year":"2021","unstructured":"Gazendam A, et al. Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials. Br J Sports Med. 2021;55(5):256\u201361.","journal-title":"Br J Sports Med"},{"issue":"2","key":"880_CR196","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10067-024-07264-0","volume":"44","author":"Q Zhou","year":"2025","unstructured":"Zhou Q, et al. A critical overview of systematic reviews and meta-analyses of intra-articular injection of platelet rich plasma versus hyaluronic acid for knee osteoarthritis. Clin Rheumatol. 2025;44(2):547\u201371.","journal-title":"Clin Rheumatol"},{"issue":"8","key":"880_CR197","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/14712598.2024.2383865","volume":"24","author":"E Kon","year":"2024","unstructured":"Kon E, et al. The chimera of reaching a universal consensus on platelet-rich plasma treatment for knee osteoarthritis: a review of recent consensus statements and expert opinion. Expert Opin Biol Ther. 2024;24(8):827\u201333.","journal-title":"Expert Opin Biol Ther"},{"key":"880_CR198","doi-asserted-by":"crossref","unstructured":"Perez AGM et al. Challenges and a feasible strategy for studies and standardization of platelet-rich plasma, in platelet-rich plasma: regenerative medicine: sports medicine, orthopedic, and recovery of musculoskeletal injuries, J.F.S.D. Lana, et al., Editors. 2014, Springer Berlin Heidelberg: Berlin, Heidelberg. pp 119\u201338.","DOI":"10.1007\/978-3-642-40117-6_4"},{"issue":"1","key":"880_CR199","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12903-020-01299-w","volume":"20","author":"RJ Miron","year":"2020","unstructured":"Miron RJ, et al. Evaluation of 24 protocols for the production of platelet-rich fibrin. BMC Oral Health. 2020;20(1):310.","journal-title":"BMC Oral Health"},{"issue":"4","key":"880_CR200","volume":"16","author":"S Yadav","year":"2024","unstructured":"Yadav S. Discussing the debate: leukocyte-rich platelet-rich plasma versus leukocyte-poor platelet-rich plasma. Cureus. 2024;16(4):e58381.","journal-title":"Cureus"},{"issue":"7","key":"880_CR201","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.arthro.2012.04.148","volume":"28","author":"JM DeLong","year":"2012","unstructured":"DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy. 2012;28(7):998\u20131009.","journal-title":"Arthroscopy"},{"issue":"1","key":"880_CR202","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsem-2015-000060","volume":"2","author":"J Magalon","year":"2016","unstructured":"Magalon J, et al. DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices. BMJ Open Sport Exerc Med. 2016;2(1):e000060.","journal-title":"BMJ Open Sport Exerc Med"},{"issue":"5","key":"880_CR203","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2217\/rme-2017-0042","volume":"12","author":"J Lana","year":"2017","unstructured":"Lana J, et al. Contributions for classification of platelet rich plasma - proposal of a new classification: MARSPILL. Regen Med. 2017;12(5):565\u201374.","journal-title":"Regen Med"},{"key":"880_CR204","doi-asserted-by":"crossref","unstructured":"Borg-Stein J et al. AAPM&R guidance statement on platelet rich plasma for knee osteoarthritis. PM R, 2026.","DOI":"10.1002\/pmrj.70144"},{"issue":"10","key":"880_CR205","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41577-024-01027-3","volume":"24","author":"Y Huang","year":"2024","unstructured":"Huang Y, Jiang W, Zhou R. DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways. Nat Rev Immunol. 2024;24(10):703\u201319.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"880_CR206","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","volume":"57","author":"M Ma","year":"2024","unstructured":"Ma M, Jiang W, Zhou R. DAMPs and DAMP-sensing receptors in inflammation and diseases. Immunity. 2024;57(4):752\u201371.","journal-title":"Immunity"},{"key":"880_CR207","doi-asserted-by":"publisher","first-page":"4139048","DOI":"10.1155\/2021\/4139048","volume":"2021","author":"B Ni","year":"2021","unstructured":"Ni B, et al. MCC950, the NLRP3 inhibitor, protects against cartilage degradation in a mouse model of osteoarthritis. Oxid Med Cell Longev. 2021;2021:4139048.","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"880_CR208","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"RC Coll","year":"2019","unstructured":"Coll RC, et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol. 2019;15(6):556\u20139.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"880_CR209","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13075-018-1664-2","volume":"20","author":"C Marchetti","year":"2018","unstructured":"Marchetti C, et al. NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis. Arthritis Res Ther. 2018;20(1):169.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"880_CR210","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.tips.2025.04.007","volume":"46","author":"JE Cabral","year":"2025","unstructured":"Cabral JE, et al. Targeting the NLRP3 inflammasome for inflammatory disease therapy. Trends Pharmacol Sci. 2025;46(6):503\u201319.","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"880_CR211","doi-asserted-by":"publisher","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","volume":"115","author":"C Marchetti","year":"2018","unstructured":"Marchetti C, et al. OLT1177, a beta-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. Proc Natl Acad Sci U S A. 2018;115(7):E1530\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"880_CR212","unstructured":"Randomized, double-blind, vehicle-controlled, efficacy and safety clinical trial of topically applied OLT1177 gel in subjects with moderate to severe pain associated with osteoarthritis of the knee following cessation of pain therapy. 2013."},{"issue":"3","key":"880_CR213","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/art.24096","volume":"61","author":"X Chevalier","year":"2009","unstructured":"Chevalier X, et al. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2009;61(3):344\u201352.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"880_CR214","doi-asserted-by":"publisher","first-page":"509","DOI":"10.7326\/M20-0527","volume":"173","author":"M Schieker","year":"2020","unstructured":"Schieker M, et al. Effects of interleukin-1beta inhibition on incident hip and knee replacement\u202f: exploratory analyses from a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2020;173(7):509\u201315.","journal-title":"Ann Intern Med"},{"issue":"6","key":"880_CR215","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1177\/03635465251330008","volume":"53","author":"CD Eliasberg","year":"2025","unstructured":"Eliasberg CD, et al. Evaluation of novel therapeutic agents for modulation of the inflammatory response in rotator cuff tendinopathy utilizing a mouse model of subacromial impingement. Am J Sports Med. 2025;53(6):1317\u201327.","journal-title":"Am J Sports Med"},{"issue":"4","key":"880_CR216","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/jor.23057","volume":"34","author":"DJ Berkoff","year":"2016","unstructured":"Berkoff DJ, et al. Use of an IL1-receptor antagonist to prevent the progression of tendinopathy in a rat model. J Orthop Res. 2016;34(4):616\u201322.","journal-title":"J Orthop Res"},{"issue":"6","key":"880_CR217","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.3892\/ijmm.2016.2770","volume":"38","author":"H Hu","year":"2016","unstructured":"Hu H, et al. Blocking of the P2X7 receptor inhibits the activation of the MMP-13 and NF-kappaB pathways in the cartilage tissue of rats with osteoarthritis. Int J Mol Med. 2016;38(6):1922\u201332.","journal-title":"Int J Mol Med"},{"issue":"1","key":"880_CR218","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s42358-024-00385-9","volume":"64","author":"M Khomeijani-Farahani","year":"2024","unstructured":"Khomeijani-Farahani M, et al. TAK-242 (Resatorvid) inhibits proinflammatory cytokine production through the inhibition of NF-kappaB signaling pathway in fibroblast-like synoviocytes in osteoarthritis patients. Adv Rheumatol. 2024;64(1):46.","journal-title":"Adv Rheumatol"},{"issue":"7","key":"880_CR219","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1002\/art.34495","volume":"64","author":"A Nair","year":"2012","unstructured":"Nair A, et al. Synovial fluid from patients with early osteoarthritis modulates fibroblast-like synoviocyte responses to toll-like receptor 4 and toll-like receptor 2 ligands via soluble CD14. Arthritis Rheum. 2012;64(7):2268\u201377.","journal-title":"Arthritis Rheum"},{"key":"880_CR220","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1602727","volume":"16","author":"K Huang","year":"2025","unstructured":"Huang K, Cai H. Hypertonic dextrose prolotherapy in osteoarthritis: mechanisms, efficacy, and future research directions. Front Endocrinol (Lausanne). 2025;16:1602727.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"880_CR221","doi-asserted-by":"publisher","DOI":"10.1177\/19476035251408601","author":"BR Harting","year":"2026","unstructured":"Harting BR, et al. In vitro model exploring the mechanisms of dextrose prolotherapy: fibroblasts exposed to clinical concentrations of dextrose exhibit significant rebound effects 48 hours after exposure. Cartilage. 2026. https:\/\/doi.org\/10.1177\/19476035251408601.","journal-title":"Cartilage"},{"issue":"3","key":"880_CR222","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.trsl.2011.02.008","volume":"158","author":"JW Freeman","year":"2011","unstructured":"Freeman JW, et al. Effect of prolotherapy on cellular proliferation and collagen deposition in MC3T3-E1 and patellar tendon fibroblast populations. Transl Res. 2011;158(3):132\u20139.","journal-title":"Transl Res"},{"issue":"8","key":"880_CR223","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s11999-017-5370-1","volume":"475","author":"EC Ekwueme","year":"2017","unstructured":"Ekwueme EC, et al. Prolotherapy induces an inflammatory response in human tenocytes in vitro. Clin Orthop Relat Res. 2017;475(8):2117\u201327.","journal-title":"Clin Orthop Relat Res"},{"issue":"11","key":"880_CR224","doi-asserted-by":"publisher","first-page":"232596712412750","DOI":"10.1177\/23259671241275087","volume":"12","author":"S Capotosto","year":"2024","unstructured":"Capotosto S, et al. Prolotherapy in the treatment of sports-related tendinopathies: a systematic review of randomized controlled trials. Orthop J Sports Med. 2024;12(11):23259671241275090.","journal-title":"Orthop J Sports Med"},{"issue":"3","key":"880_CR225","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ctim.2015.04.003","volume":"23","author":"D Rabago","year":"2015","unstructured":"Rabago D, et al. Hypertonic dextrose injection (prolotherapy) for knee osteoarthritis: long term outcomes. Complement Ther Med. 2015;23(3):388\u201395.","journal-title":"Complement Ther Med"},{"issue":"3","key":"880_CR226","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1370\/afm.2520","volume":"18","author":"RWS Sit","year":"2020","unstructured":"Sit RWS, et al. Efficacy of intra-articular hypertonic dextrose (prolotherapy) for knee osteoarthritis: a randomized controlled trial. Ann Fam Med. 2020;18(3):235\u201342.","journal-title":"Ann Fam Med"},{"key":"880_CR227","doi-asserted-by":"crossref","unstructured":"Waluyo Y et al. Efficacy of prolotherapy for osteoarthritis: a systematic review. J Rehabil Med. 2023;55:jrm00372.","DOI":"10.2340\/jrm.v55.2572"},{"issue":"11","key":"880_CR228","first-page":"5663","volume":"9","author":"HR Farpour","year":"2017","unstructured":"Farpour HR, Fereydooni F. Comparative effectiveness of intra-articular prolotherapy versus peri-articular prolotherapy on pain reduction and improving function in patients with knee osteoarthritis: a randomized clinical trial. Electr Phys. 2017;9(11):5663\u20139.","journal-title":"Electr Phys"},{"issue":"2","key":"880_CR229","doi-asserted-by":"publisher","DOI":"10.5812\/aapm-140966","volume":"14","author":"S Ebnerasooli","year":"2024","unstructured":"Ebnerasooli S, et al. Peri-articular dextrose prolotherapy: investigating the effect of injection site on knee osteoarthritis pain: a double-blind, randomized, clinical trial. Anesth Pain Med. 2024;14(2):e140966.","journal-title":"Anesth Pain Med"},{"issue":"1","key":"880_CR230","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13018-024-04762-4","volume":"19","author":"Y Fu","year":"2024","unstructured":"Fu Y, et al. Demonstrating the effectiveness of intra-articular prolotherapy combined with peri-articular perineural injection in knee osteoarthritis: a randomized controlled trial. J Orthop Surg Res. 2024;19(1):279.","journal-title":"J Orthop Surg Res"},{"issue":"6","key":"880_CR231","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1177\/02692155221086213","volume":"36","author":"YW Chen","year":"2022","unstructured":"Chen YW, et al. Effectiveness, compliance, and safety of dextrose prolotherapy for knee osteoarthritis: a meta-analysis and metaregression of randomized controlled trials. Clin Rehabil. 2022;36(6):740\u201352.","journal-title":"Clin Rehabil"},{"key":"880_CR232","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2025.11.032","author":"RW Sit","year":"2025","unstructured":"Sit RW, et al. Dextrose prolotherapy injection improves dynamic postural balance and reduces risk of recurrent sprains in chronic ankle instability: a 1-year randomized placebo-controlled trial. Arch Phys Med Rehabil. 2025. https:\/\/doi.org\/10.1016\/j.apmr.2025.11.032.","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"880_CR233","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/bjsm.2009.057968","volume":"45","author":"MJ Yelland","year":"2011","unstructured":"Yelland MJ, et al. Prolotherapy injections and eccentric loading exercises for painful Achilles tendinosis: a randomised trial. Br J Sports Med. 2011;45(5):421\u20138.","journal-title":"Br J Sports Med"},{"issue":"11","key":"880_CR234","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.7150\/ijms.24170","volume":"15","author":"SW Tsai","year":"2018","unstructured":"Tsai SW, et al. Effects of dextrose prolotherapy on contusion-induced muscle injuries in mice. Int J Med Sci. 2018;15(11):1251\u20139.","journal-title":"Int J Med Sci"},{"issue":"1","key":"880_CR235","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.pmr.2022.08.011","volume":"34","author":"C Hsu","year":"2023","unstructured":"Hsu C, Vu K, Borg-Stein J. Prolotherapy: a narrative review of mechanisms, techniques, and protocols, and evidence for common musculoskeletal conditions. Phys Med Rehabil Clin N Am. 2023;34(1):165\u201380.","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"23","key":"880_CR236","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1136\/bjsports-2016-096419","volume":"50","author":"NL Millar","year":"2016","unstructured":"Millar NL, Dean BJ, Dakin SG. Inflammation and the continuum model: time to acknowledge the molecular era of tendinopathy. Br J Sports Med. 2016;50(23):1486.","journal-title":"Br J Sports Med"},{"issue":"6","key":"880_CR237","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/bjsports-2017-098161","volume":"52","author":"SG Dakin","year":"2018","unstructured":"Dakin SG, et al. Chronic inflammation is a feature of Achilles tendinopathy and rupture. Br J Sports Med. 2018;52(6):359\u201367.","journal-title":"Br J Sports Med"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-026-00880-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-026-00880-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-026-00880-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:09:56Z","timestamp":1790683796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-026-00880-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":237,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["880"],"URL":"https:\/\/doi.org\/10.1007\/s40122-026-00880-5","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"28 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ryan John Love, Jay Sheridan, Christopher Funk, and Jody-Lynn Young have nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}